← Back to Science And Tech Overview

Subject: Science And Tech | Published: 17 November 2025

Vaccine technology & India's immunization strategy: a 2025 UPSC analysis

📚

Recommended UPSC Book List

Access the curated list of standard books and resources used by top aspirants for all subjects.

Join Channel Now →

The Science of Immunity: How Vaccines Work

Immunization is the process by which an individual’s immune system becomes fortified against an agent, known as an immunogen. A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. The basic principle is to introduce a safe and controlled form of a pathogen—or a piece of it—to the body. This component, known as an antigen, is enough to stimulate an immune response but insufficient to cause the actual disease.

When a vaccine is administered, specialized immune cells recognize the antigen as foreign. This triggers a cascade:

  1. B-lymphocytes (B-cells) are activated to produce antibodies, which are proteins that can neutralize the real pathogen by binding to its surface.
  2. T-lymphocytes (T-cells) are also activated. Helper T-cells coordinate the immune response, while Killer T-cells can destroy infected host cells.
  3. Crucially, the immune system creates memory B-cells and T-cells. These cells persist for years, sometimes a lifetime. If the individual is later exposed to the actual pathogen, these memory cells mount a rapid and powerful response, preventing the disease from taking hold.

Fun Fact: The concept of inoculation dates back centuries, but the first modern vaccine was created by Edward Jenner in 1796. He used cowpox material to create immunity to smallpox, a disease that has now been completely eradicated through vaccination, saving an estimated 5 million lives annually.

Types of Vaccine Platforms

Vaccine technology has evolved significantly. Different platforms are used based on the nature of the pathogen and the desired immune response.

Vaccine TypeMechanismExamplesAdvantagesDisadvantages
Live-AttenuatedContains a weakened (attenuated) version of the living virus or bacteria.Measles, Mumps, Rubella (MMR), Oral Polio Vaccine (OPV), BCG (Tuberculosis)Strong, long-lasting immune response; often lifelong immunity with one or two doses.May cause mild infection; not suitable for immunocompromised individuals; requires strict cold chain.
InactivatedContains the killed version of the pathogen that causes a disease.Inactivated Polio Vaccine (IPV), Covaxin, Hepatitis ASafer than live vaccines; stable and easier to store; suitable for immunocompromised people.Weaker immune response; often requires multiple booster doses.
Subunit, Recombinant, Polysaccharide, and ConjugateContains only specific pieces of the pathogen, like its protein, sugar, or capsid.Hepatitis B, HPV, Pertussis (part of DTaP), Pneumococcal diseaseVery safe as they cannot cause the disease; good for people with weakened immune systems.May require adjuvants (substances to enhance immune response) and booster shots.
ToxoidContains a toxin made by the pathogen that has been inactivated.Tetanus, Diphtheria (part of DTaP)Protects against diseases caused by toxins, not the pathogen itself.Requires booster shots to maintain immunity.
mRNA (Messenger RNA)Uses genetically engineered mRNA to give cells instructions to make the antigen protein.Pfizer-BioNTech & Moderna COVID-19 vaccinesVery rapid development and production; high efficacy; robust B-cell and T-cell response.Requires ultra-cold storage; newer technology with less long-term data.

Mnemonic for Vaccine Types: To remember the major vaccine platforms, think “LISA-ToNight”: Live-attenuated, Inactivated, Subunit, Acellular, Toxoid, Nucleic acid (mRNA/DNA).

India’s Immunization Programs: From UIP to IMI 5.0

India’s public vaccination efforts are anchored by the Universal Immunization Programme (UIP), one of the largest public health programs in the world. It provides free vaccines against 12 life-threatening diseases.

To boost coverage, the government launched Mission Indradhanush in 2014. Its goal was to rapidly increase immunization coverage to 90% for all children and pregnant women.

Recent Development (2023): The program has been significantly updated with the launch of Intensified Mission Indradhanush (IMI) 5.0. This latest phase, conducted between August and October 2023, marked a major strategic shift:

  • It was the first time the campaign was conducted in all districts across the country.
  • It included children up to 5 years of age (previously 2 years).
  • A primary focus was on reaching “zero-dose” children—those who have not received even a single vaccine dose.
  • It saw the nationwide rollout of the U-WIN platform, a digital system designed to register and track each pregnant woman and child for their vaccination status, sending reminders and maintaining a permanent digital record. This is modeled on the success of the Co-WIN platform.

Fun Fact: Herd immunity is a critical benefit of widespread vaccination. When a high percentage of the population is immune, it creates a protective barrier that makes it difficult for a disease to spread, thus safeguarding vulnerable individuals who cannot be vaccinated. It’s like creating firebreaks in a forest to stop a wildfire.

Global Framework: From GVAP to Immunization Agenda 2030

The global strategy for vaccination has also evolved. The Global Vaccine Action Plan (GVAP) 2011-2020 was a framework endorsed by the World Health Assembly to extend the benefits of immunization to all.

Its successor is the Immunization Agenda 2030 (IA2030): A Global Strategy to Leave No One Behind. IA2030 envisions a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and well-being. It is more ambitious, focusing on a life-course approach to immunization and emphasizing the role of vaccination in achieving the Sustainable Development Goals (SDGs).

Critical Policy Appraisal

Challenges / CriticismsOpportunities / Successes / Way Forward
Vaccine Hesitancy: Misinformation and lack of awareness, especially in remote areas, hinder uptake.U-WIN Platform: Digital tracking and reminders can significantly improve compliance and reduce dropout rates.
Cold Chain Logistics: Maintaining the cold chain for temperature-sensitive vaccines in a country with diverse geography and power-supply issues is a constant challenge.Pharma Manufacturing Hub: India’s status as the ‘pharmacy of the world’ allows for large-scale, low-cost vaccine production and potential for ‘Vaccine Maitri 2.0’.
Reaching the Last Mile: Despite programs like IMI, reaching migrant populations, tribal communities, and urban slum dwellers remains difficult.Focus on Next-Gen Tech: Post-COVID, increased investment in mRNA and other advanced platforms can lead to faster responses for future pandemics and new vaccines (e.g., for Dengue, Malaria).
Data Gaps: Accurate, real-time data on vaccine coverage and disease surveillance is still patchy in some regions.Integrated Health Services: Linking immunization with nutrition and other primary healthcare services can improve overall health outcomes and build trust.

Analytical Lens: UPSC Focus (Mains & Prelims)

Conceptual Basis

The legal and constitutional foundation for India’s public health and vaccination initiatives is derived from:

  • Article 21 (Right to Life): The Supreme Court has interpreted this to include the Right to Health, making it an obligation for the state to provide for public health.
  • Article 47 (Directive Principles of State Policy): This article directs the State to raise the level of nutrition and the standard of living and to improve public health, making the control of epidemics a primary duty.
  • National Health Policy (2017): Aims to achieve universal health coverage and deliver quality health care services to all at affordable costs, with a specific focus on preventive and promotive health.

UPSC Integration: Connecting the Dots

  • Polity & Governance: Health is a State List subject, but disease control and national health programs require strong cooperative federalism. The response to COVID-19 and the rollout of IMI 5.0 are prime examples of Centre-State coordination.
  • Economy: The Indian pharmaceutical industry is a major economic driver. Issues of Intellectual Property Rights (IPR), compulsory licensing (under the TRIPS agreement), and public vs. private investment in R&D are critical economic dimensions of vaccine policy.
  • International Relations: India’s ‘Vaccine Maitri’ initiative was a significant exercise in soft power and health diplomacy. Global vaccine equity and India’s role in global health security (e.g., through GAVI, WHO) are key IR topics.

Future Outlook

The future of vaccinology is moving towards personalized medicine, with mRNA platforms offering the potential for rapid development of vaccines against cancers and other non-communicable diseases. For India, the key challenge will be to leverage its manufacturing prowess with enhanced R&D capabilities to achieve self-reliance in next-generation vaccine technology. The success of the U-WIN platform will be critical in building a robust public health data infrastructure, essential for evidence-based policymaking and future pandemic preparedness.

Prelims Practice Question (MCQ)

With reference to the recently launched Intensified Mission Indradhanush (IMI) 5.0, consider the following statements:

  1. It exclusively targets children up to the age of 2 years who have missed their vaccine doses.
  2. It aims to digitize the vaccination records for all children and pregnant women through the U-WIN platform.
  3. For the first time, the campaign was implemented in all districts of the country simultaneously.

Which of the statements given above is/are correct? (a) 1 and 2 only (b) 2 and 3 only (c) 3 only (d) 1, 2 and 3

Answer: (b) Explanation: Statement 1 is incorrect; IMI 5.0 expanded the target age group to include children up to 5 years to catch up on missed doses. Statements 2 and 3 are correct. The nationwide rollout of the U-WIN platform and the implementation across all districts are key features of IMI 5.0.

Mains Practice Question

“While India has demonstrated remarkable capacity in vaccine manufacturing, the challenges of equitable delivery and future pandemic preparedness require a paradigm shift from mere production to integrated R&D and digital health infrastructure.” Analyze this statement in the context of lessons learned from the COVID-19 pandemic and recent government initiatives. (15 Marks, 250 Words)


Mind Map Outline (Revision Structure)

  • Vaccines: Science and Policy
    • Core Principle
      • Introduction of an Antigen
      • Stimulation of Adaptive Immune System
        • B-Cells -> Antibodies
        • T-Cells -> Cellular Immunity
        • Creation of Immunological Memory
    • Vaccine Platforms (The “LISA-ToNight” Mnemonic)
      • Live-Attenuated
        • Mechanism: Weakened pathogen
        • Example: MMR, OPV
      • Inactivated
        • Mechanism: Killed pathogen
        • Example: IPV, Covaxin
      • Subunit/Recombinant
        • Mechanism: Specific pieces of pathogen
        • Example: Hepatitis B
      • Toxoid
        • Mechanism: Inactivated toxin
        • Example: Tetanus
      • Nucleic Acid (mRNA)
        • Mechanism: Genetic instructions for antigen
        • Example: Pfizer, Moderna
    • India’s Immunization Framework
      • Universal Immunization Programme (UIP)
        • Foundation of public vaccination
        • Free vaccines for 12 diseases
      • Mission Indradhanush (MI)
        • Objective: Boost coverage to 90%
        • Intensified Mission Indradhanush (IMI) 5.0 (2023 Update)
          • Target: Children up to 5 years, zero-dose children
          • Scope: All districts nationwide
          • Digital Backbone: U-WIN Platform
    • Policy & Governance
      • Constitutional Basis
        • Article 21: Right to Health
        • Article 47: DPSP on Public Health
      • Critical Appraisal
        • Challenges: Vaccine hesitancy, logistics, last-mile delivery
        • Opportunities: U-WIN, manufacturing strength, ‘Vaccine Maitri’
      • Global Context
        • Shift from GVAP to Immunization Agenda 2030 (IA2030)
        • India’s Role: Health diplomacy and global supply

From the makers of these notes

Revise this on your phone — in your own language

EduOrbex turns the UPSC, State PSC, SSC and RRB syllabus into narrated study songs, step-by-step aptitude video-lessons and an interactive India map quiz — in English, Hindi, Telugu, Tamil, Kannada and Malayalam. Completely free.

  • Narrated aptitude lessons, every step explained aloud
  • Thousands of practice questions with hints
  • Map quiz on real Survey of India boundaries
  • Download and study with no network